Combination of bone allograft, barrier membrane and doxycycline in the treatment of infrabony periodontal defects: A comparative trial
- PMID: 26236130
- PMCID: PMC4501465
- DOI: 10.1016/j.sdentj.2015.01.003
Combination of bone allograft, barrier membrane and doxycycline in the treatment of infrabony periodontal defects: A comparative trial
Abstract
Aim: The purpose of the present study was to compare the regenerative potential of noncontained periodontal infrabony defects treated with decalcified freeze-dried bone allograft (DFDBA) and barrier membrane with or without local doxycycline.
Methods: This study included 48 one- or two-wall infrabony defects from 24 patients (age: 30-65 years) seeking treatment for chronic periodontitis. Defects were randomly divided into two groups and were treated with a combination of DFDBA and barrier membrane, either alone (combined treatment group) or with local doxycycline (combined treatment + doxycycline group). At baseline (before surgery) and 3 and 6 months after surgery, the pocket probing depth (PPD), clinical attachment level (CAL), radiological bone fill (RBF), and alveolar height reduction (AHR) were recorded. Analysis of variance and the Newman-Keuls post hoc test were used for statistical analysis. A two-tailed p-value of less than 0.05 was considered to be statistically significant.
Results: In the combined treatment group, the PPD reduction was 2.00 ± 0.38 mm (32%), CAL gain was 1.25 ± 0.31 mm (17.9%), and RBF was 0.75 ± 0.31 mm (20.7%) after 6 months. In the combined treatment + doxycycline group, these values were 2.75 ± 0.37 mm (44%), 1.5 ± 0.27 mm (21.1%), and 1.13 ± 0.23 mm (28.1%), respectively. AHR values for the groups without and with doxycycline were 12.5% and 9.4%, respectively.
Conclusion: There was no significant difference in the regeneration of noncontained periodontal infrabony defects between groups treated with DFDBA and barrier membrane with or without doxycycline.
Keywords: Bone grafting; Doxycycline; Guided tissue regeneration.
Figures






References
-
- Aimetti M., Romano F., Pigella E., Pranzini F., Debernardi C. Treatment of wide, shallow, and predominantly 1-wall infrabony defects with a bioresorbable membrane: a randomize controlled clinical trial. J. Periodontol. 2005;76:1354–1361. - PubMed
-
- Chaturvedi R., Gill A.S., Sikri P. Evaluation of the regenerative potential of 25% doxycycline-loaded biodegradable membrane vs biodegradable membrane alone in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J. Dent. Res. 2008;19:116–123. - PubMed
-
- Chen C.C., Wang H.L., Smith F., Glickman G.N., Shyr Y.N.R. Evaluation of collagen membrane with and without bone grafts in treating periodontal infrabony defects. J. Periodontol. 1995;66:838–847. - PubMed
-
- Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors. 2004;22:233–241. - PubMed
LinkOut - more resources
Full Text Sources